Purchases and Sales Made in Q2 2023 in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT) during Q2 2023. The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2023
Q2 2023
|
Hamilton Lane Advisors LLC
|
SELL
|
- |
-69K- 83.33% |
$36.6K - $249K
|
13.8K
$31.3K
|